84314-02-3

Upstream product

• 84314-04-5 4-(4-chloro-3-nitrophenyl)-4-oxobutanoic acid 
• 56872-65-2 3-(3-nitro-4-morpholino-benzoyl)-propionic acid 
• 288309-07-9 3-acetyl-6-fluorobenzenecarbonitrile 
• 544-92-3 copper(I) cyanide 
• 65854-68-4 3-(3-amino-4-morpholino-benzoyl)propionic acid 

Downstream Products

• 84314-03-4 2-(morpholin-4-yl)-5-(6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)benzonitrile 
• 103604-63-3 5-(4-Ethyl-6-oxo-1,4,5,6-tetrahydro-pyridazin-3-yl)-2-morpholin-4-yl-benzonitrile 
• 102625-20-7 2-Morpholin-4-yl-5-(5-oxo-tetrahydro-furan-3-carbonyl)-benzonitrile 
• 102625-15-0 6-(3-cyano-4-morpholino-phenyl)-5-hydroxymethyl-4,5-dihydro-3(2H)-pyridazinone 

Relevant academic research and scientific papers

6-PHENYL-4,5-DIHYDROPYRIDAZIN-3(2H)-ONE DERIVATIVES AS PDE3A AND PDE3B INHIBITORS FOR TREATING CANCER

The present invention provides 6-phenyl-4,5-dihydropyridazin-3(2H)- one derivatives of formula (I) : The present invention provides 6-phenyl-4,5-dihydropyridazin-3(2H)- one derivatives of formula (I) :

6-(4-Morpholino-phenyl)-4,5-dihydro-2H-pyridazine-3-ones: potent platelet aggregation inhibitors and antithrombotics

A series of di- and tri-substituted 6-phenyl-4,5-dihydro-2H-pyridazine-3-ones is described.The compounds were designed to be antithrombotics and were assessed for their inhibitory properties on platelet aggregation and on thrombus formation in an arteriov